Atlas Venture Opportunity Fund II, L.P. - Insider Trading & Ownership

Entity: Company
Location: 300 Technology Square, 8 Th Floor, Cambridge, MA
Summary: The estimated value of insider holdings of Atlas Venture Opportunity Fund II, L.P. is at least $90.8M dollars as of April 23, 2024. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $44.5M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $20.6M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $14.8M. Atlas Venture Opportunity Fund II, L.P. is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $10.9M.
All Insider Reports: All Insider Reports

Ownership of Atlas Venture Opportunity Fund II, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DYN	Dyne Therapeutics, Inc.	10%+ Owner	$44.5M			Dec 12, 2022
DAWN	Day One Biopharmaceuticals, Inc.	10%+ Owner	$20.6M			Jun 17, 2022
IRON	Disc Medicine, Inc.	10%+ Owner	$14.8M			Dec 29, 2022
KRRO	Korro Bio, Inc.	10%+ Owner	$10.9M	+$1M	+10.1%	Apr 22, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.